Ladenburg Thalmann Downgrades Sequenom (SQNM) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Sequenom, Inc. Shares 2015 Investor And Analyst Day Presentation
September 28, 2015 2:00 PM EDTSAN DIEGO, Sept. 28, 2015 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today is hosting its 2015 investor and analyst day in New York, NY.
The presentation, which includes a discussion of the Company's corporate vision and plans for reproductive health and oncology testing, is now available on the... More
Sequenom, Inc. Updates Second Half 2015 Revenue Outlook
September 25, 2015 7:00 AM EDTSAN DIEGO, Sept. 25, 2015 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, provides its current revenue outlook for the second half of 2015.
The Company is updating its revenue expectations for the second half of the year to a range between $57 million and $61 million, bringing 2015 annual revenue expectations to a range between $127 million and $131 million.
Drivers for the updated expectations include increased competition and price compression in the noninvasive prenatal testing (NIPT)... More
